$1.41
-0.01 (-0.70%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+393.6% upside
Low Target
$5.52
Average Target
$6.96
High Target
$10.50
Current Price
$1.41
Current
$1.41
$1.41
Target
$6.96
$6.96
$5.52
$6.96 avg
$10.50
Scenario Analysis
Bear Case
$5.52
291.5%
Low target
Base Case
$6.96
+393.6%
Avg target
Bull Case
$10.50
+644.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$1.88
-25.0% from high
52-Week Low
$0.81
+74.1% from low
Target vs 52W High
$6.96
+270.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |